Law360 Covers Customs Fraud Whistleblower Settlement in Case Brought by Jeff Newman Law

On November 10, 2022, Law360 published an article, “Calif. Importer Pays $3.25M To End Customs Fraud Case,” on a recent settlement in a customs fraud False Claims Act qui tam case brought by Jeff Newman Law. In the case, whistleblower Chris Chan, a Hong Kong resident, alleged that a California-based importer was evading tariffs on Chinese merchandise by understating the prices it paid for the goods.

Akorn to Pay $7.9 Million to Resolve Medicare Fraud Claims

On September 15, 2022, the Department of Justice announced a $7.9 million settlement with pharmaceutical company Akorn to resolve False Claims Act allegations in a qui tam case that Jeff Newman Law filed on behalf of its client, Albermarle, LLC.

Click here to read the story.

Jeff Newman Law Firm Lauds The Decision Of The U.S. Treasury To Create New Whistleblower Rewards Program To Recover Stolen Assets By Russian Elites Seeking To Evade U.S. Sanctions

Click here to read the report.

Modern Healthcare features article on major whistleblower case against Equity Finance Company and Counsel for the whistleblower, Jeffrey A. Newman

Click here to read the report.

Wall Street Journal features case of whistleblower represented by Jeffrey A. Newman.

Read the article in the Wall Street Journal.

Jeffrey Newman featured in compliance newsletter for record settlement

Click here to read the report.

Jeffrey Newman quoted in the Boston Globe about his recent HIG settlement, the largest publicly disclosed government health care fraud settlement in the nation involving private equity oversight of health care providers.

Click here to read the full article

Marblehead attorney lands largest settlement against a national therapy company servicing patients in skilled nursing facilities

It took more than a few nights and weekends pouring over documents and constructing detailed spreadsheets with her lawyer, Jeffrey A. Newman of Marblehead, but Janet Halpin can now say it was all worth it… Read More.